At Omega Therapeutics, we are pioneering the discovery of epigenomic targets to develop a new class of therapeutics to fundamentally transform human medicine in the service of patients. Our objective is to become the leading digital and data-driven epigenetic medicines company by discovering and developing Omega Epigenomic Controllers (OECs), utilizing the OMEGA Epigenomic Programming™ platform, with the vision of selectively directing the human genome to treat and cure serious diseases.
Mahesh Karande
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.